ICER delves into potential funding models for COVID-19 products
The Institute for Clinical and Economic Review (ICER) has examined a range of funding models that could be used for … read more »
Bipartisan Bill to examine pharma supply chains in the US
Marco Rubio and Elizabeth Warren, US Senators from the Republican and Democratic Parties respectively, have drafted legislation to investigate how … read more »
FDA sets out standards for COVID-19 vaccine
The US Food and Drugs Administration (FDA) has announced the guidelines it will follow when examining vaccines for the pandemic … read more »
Video game as therapy: FDA makes landmark ADHD approval
The US Food and Drugs Administration (FDA) has approved a video game as a treatment for attention deficit hyperactive disorder … read more »
Pushback on US plan to bring supply chain on-shore
The Trump administration proposal to encourage or even enforce US-based manufacturing in the pharmaceutical industry has received strong pushback from … read more »
Medicare proposes payment increase for CAR-T therapy
Hospitals administering CAR-T therapies will be eligible for Medicare payment increases in 2021, better reflecting actual treatment costs. The US … read more »
NIH guidelines emphasise lack of evidence for COVID-19 treatments
The National Institutes of Health (NIH) has released a set of guidelines explaining the optimal management of coronavirus patients. The … read more »
FDA to permit compounding of certain drugs during pandemic
In order to cope with expected shortages of some medicines for hospitalised patients, the US Food and Drugs Administration will … read more »
NIH announces public-private partnership against COVID-19
The US National Institutes of Health (NIH) and Foundation for the NIH (FNIH) have launched a collaboration between industry and … read more »
Pharma companies readying COVID-19 relief funds
Some of the biggest companies in the pharmaceutical sector are preparing relief packages to support the public and healthcare providers … read more »
